*Data from MSF International Activity Report 2024

Tajikistan 2018 © Sabir Sabirov
Tajikistan
Developing innovative approaches to reduce tuberculosis (TB) incidence and death rates.
Our work in Tajikistan
Doctors Without Borders/Médecins Sans Frontières (MSF) has been involved in tuberculosis (TB) care in Tajikistan for many years, developing strategies to reduce the incidence in high-burden regions through community engagement and sustainable health care practices.
How we're helping in Tajikistan
In Kulob district of Khatlon region in southwestern Tajikistan, we continue to run our Zero TB project, which is designed to demonstrate the feasibility of eliminating TB in geographically contained areas with appropriate treatment and preventive strategies. Our holistic approach comprises social assistance, mental health support, and adherence counseling, as well as medical care, ensuring effective treatment. Our project uses advanced technology, such as digital X-rays, to facilitate early detection of the disease.
In June, we handed over our comprehensive TB care project in Dushanbe, which we had been running for 13 years, to the Ministry of Health and Social Protection of Population. The project focused on improving TB detection, treatment and support, especially for children and their adult family members, as well as the staff of and people incarcerated in prisons. Through innovative methods such as F-DOT (family directly observed therapy), which allows patients to take their medication at home under the supervision of a family member, MSF empowered patients and involved the community in TB control. During our time in Dushanbe, we achieved many milestones, including the introduction of better diagnostic tools and new medicines such as bedaquiline and delamanid.
MSF continued to support the national TB program and the Ministry of Health and Social Protection of Population to implement shorter, all-oral treatment regimens for both drug-resistant and drug-sensitive TB and initiated the first cohort of eligible patients in 2024.

How we're helping
11
People started on treatment for multi-drug resistant TB (MDR-TB)
More news and stories
Learn about MSF’s journalistic roots and our commitment to bear witness and speak out about the plight of the people we treat.

Story Mar 24, 2022
Tajikistan: Innovative MSF project improves pediatric tuberculosis car...
Read moreLearn about MSF’s journalistic roots and our commitment to bear witness and speak out about the plight of the people we treat.